| 49.89 Data as of May 10 |  +4.22 / +9.24%Today’s Change | 39.73 Today|||52-Week Range 55.06 | +6.63% Year-to-Date |
| Advisory Board Beats on Both Top and Bottom Lines May 10 / MotleyFool.com | It's Showtime for Advisory Board May 06 / MotleyFool.com |
| Previous close | 45.67 |
| Today’s open | 46.66 |
| Day’s range | 46.66 - 50.97 |
| Volume | 802,950 |
| Average volume (3 months) | 286,885 |
| Market cap | $1.8B |
| Dividend yield | -- |
| Earnings growth (last year) | +18.58% |
| Earnings growth (this year) | +5.84% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +27.60% |
| P/E ratio | 83.2 |
| Price/Sales | 3.93 |
| Price/Book | 7.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALNYAlnylam Pharmaceutic... | +0.85 | +3.43% |
| ICLRICON PLC | +0.48 | +1.49% |
| ISISIsis Pharmaceuticals... | +0.53 | +2.87% |
| CRLCharles River Labora... | +0.59 | +1.35% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $0.29 |
| Annual revenue (last year) | $370.3M |
| Annual profit (last year) | $23.1M |
| Net profit margin | 6.17% |
Sector Health Services |
Industry Services to the Health Industry |
President David L. Felsenthal, MBA |
Chief Executive Officer & Director Robert W. Musslewhite |
Corporate headquarters Washington, District Of Columbia |
.
